Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging

Journal of Nuclear Medicine

Volumn 45, Issue 4, 2004, Pages 543-552

  Scarfone, Christopher ^a,b   Lavely, William C ^a,d   Cmelak, Anthony J ^a,b   Delbeke, Dominique ^a   Martin, William H ^a   Billheimer, Dean ^b   Hallahan, Dennis E ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Conformal radiotherapy; Head and neck cancer; Nuclear medicine treatment planning; PET; Radiotherapy targets

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; FEASIBILITY STUDY; HEAD AND NECK TUMOR; IMAGE SUBTRACTION; METHODOLOGY; PROSPECTIVE STUDY; RADIATION DOSE; RADIOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 2542420138     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer Statistics 2000. CA-A Cancer J Clin. 2000;50:7-33.
2. Norris CM, Busse PM, Clark JR. Evolving role of surgery after induction chemotherapy and primary site radiation in head and neck cancer. Semin Surg Oncol. 1993;9:3-13.
3. Khoo VS, Dearnaley DP, Finnigan DJ, Padhani A, Tanner SF, Leach MO. Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning. Radiother Oncol. 1997;42:1-15.
4. 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys. 2002;53:1051-1057.
5. Bentel GC. Radiation Therapy Planning. 2nd ed. New York, NY: McGraw-Hill; 1996.
6. Klausner R. Vision of cancer, from a molecular, cell biology perspective: integration with imaging. National Cancer Institute: Industry Forum on Biomedical Imaging in Oncology; Washington, DC: National Cancer Institute; 1999.
7. Munley MT, Marks LB, Scarfone C, et al. Multimodality nuclear medicine imaging for 3D lung radiotherapy: challenges and prospects. Lung Cancer. 1999;23:105-114.
8. Marks LB, Spencer RP, Bentel GC, et al. The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. Int J Radiat Oncol Biol Phys. 1993;26:659-668.
9. Grosu A-L, Weber W, Feldmann HJ, et al. First experience with I-123-alpha-methyl-tyrosine SPECT in the 3-D radiation treatment planning of brain gliomas. Int J Radiat Oncol Biol Phys. 2000;47:517-526.
10. Cattaneo GM, Rizzo G, Lombardi P, et al. Integration of computerized tomography imaging with single photon emission in a commercial system for developing radiotherapy fields: application to conformational irradiation for lung carcinoma. Radiol Med (Torino). 1999;97:272-278.
11. Pardo FS, Aronen HJ, Kennedy D, et al. Functional cerebral imaging in the evaluation of radiotherapeutic treatment planning of patients with malignant glioma. Int J Radiat Oncol Biol Phys. 1994;30:663-669.
12. Scarfone C, Jaszczak RJ, Munley MT, et al. Quantitative pulmonary SPECT for radiotherapy applications. Med Phys. 1999;26:1579-1587.
13. Itoh M, Matsuzawa T, Hatazawa J, et al. Applications of positron emission tomography to therapeutic oncology. Acta Radiol. 1991;376(suppl):45-49.
14. Austin-Seymour M, Chen GTY, Rosenman J, Michalski J, Lindsley K, Goitein M. Tumor and target delineation: current research and future challenges. Int J Radiat Oncol Biol Phys. 1995;33:1041-1052.
15. Kessler M. Integration of multimodality image data for three-dimensional treatment planning. In: Purdy JA, Fraass BA, eds. Syllabus: A Categorical Course in Physics, Three-Dimensional Radiation Therapy Treatment Planning. Oak Brook, IL: Radiological Society of North America; 1994:31-39.
16. Kuszky BS, Ney DR, Fishman EK. The current state of the art in three dimensional oncologic imaging: an overview. Int J Radiat Oncol Biol Phys. 1995;27:1029-1039.
17. Kessler ML, Pitluck S, Petti P, Castro JR. Integration of multimodality image data for radiotherapy treatment planning. Int J Radiat Oncol Biol Phys. 1991;21:1653-1667.
18. Purdy JA. Advances in three-dimensional treatment planning and conformal dose delivery. Semin Oncol. 1997;24:655-672.
19. Shields AF, Mankoff DA, Link JM, et al. Carbon-11-thymidine and FDG to measure therapy response. J Nucl Med. 1998;39:1757-1762.
20. Koh WJ, Bergman KS, Rasey JS, et al. Evaluation of oxygen status during fractionated radiotherapy in human non-small cell lung cancers using [F-18] fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys. 1995;33:391-398.
21. Sugawara Y, Eisbruch A, Carlson SM, Kison PV, Wahl RL. Evaluation of FDG-PET before and after radiation therapy in patients with cervical cancer. J Nucl Med. 1999;40:1125-1131.
22. Hustinx R, Eck SL, Alavi A. Potential applications of PET imaging in developing novel cancer therapies. J Nucl Med. 1999;40:995-1002.
23. 18F-FDG-PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med Mol Imaging. 1998;25:1255-1260.
24. D'Amico TA, Wong TZ, Harpole DH, Brown SD, Coleman RE. Impact of computed tomography-positron emission computed tomography fusion in staging patients with thoracic malignancies. Ann Thorac Surg. 2002;74:160-163.
25. Vansteenkiste JF, Stoobants SG, Dupont PJ, et al. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic CT-PET fusion images improve the localization of regional lymph node metastases? Eur J Nucl Med. 1998;25:1459-1501.
26. Townsend DW, Cherry SR. Combining anatomy and function: the path to true image fusion. Eur Radiol. 2001;11:1968-1974.
27. Wahl RL, Quint LE, Cieslank RD, Aisen AM, Koeppe RA, Meyer CR. "Anatometabolic" tumor imaging: fusion of FDG-PET with CT or MRI to localize foci of increased activity. J Nucl Med. 1993;34:1190-1197.
28. Mongioj V, Brusa A, Loi G, et al. Accuracy evaluation of fusion of CT, MR and SPECT images using commercially available software packages (SRS, PLATO, and IFS). Int J Radiat Oncol Biol Phys. 1998;43:227-234.
29. Mutic S, Dempsey JF, Bosch WR, et al. Multimodality image registration quality assurance for conformal three-dimensional treatment planning. Int J Radiat Oncol Biol Phys. 2001;51:255-260.
30. Armstrong JG. Target volume definition for three-dimensional conformal radiation therapy of lung cancer. Br J Radiol. 1998;71:587-594.
31. Ahnesjo A, Aspradakis MM. Dose calculation for external photon beams in radiotherapy. Phys Med Biol. 1999;44:R99-R155.
32. Newcomb CH, van Dyk J, Hill RP. The role of magnetic resonance for assessing radiation-induced lung damage. Int J Radiat Oncol Biol Phys. 1994;30:125-132.
33. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 2002;53:1111-1116.
34. Cozzi L, Fogliata A. IMRT in the treatment of head and neck cancer: is the present already the future? Expert Rev Anticancer Ther. 2002;2:297-308.
35. Gambhir SS, Czernin J, Schwimmer J, Silverman DHS, Coleman RE, Phelps ME. A tabulated summary of the FDG-PET literature. J Nucl Med. 2001;42:1S-93S.
36. Delbeke D, Martin WH, Patton JA, Sandler MP. Practical FDG Imaging: A Teaching File. New York, NY: Springer Verlag; 2002.
37. 18FDG-PET. Nuklearmedizin. 2002;41:217-220.
38. Scarfone C, Morgan V, Rohde GH, et al. Combined anatomical and functional imaging for conformal radiotherapy [abstract]. J Nucl Med. 2000;41(suppl):273P.
39. Lavely WC, Scarfone C, Cevikalp H, et al. CT/PET image coregistration: an assessment of accuracy for two software programs. Med Phys. In press.
40. 18F-FDG PET in candidates for radiation therapy: is it important and how do we validate its impact? J Nucl Med. 2003;44:30-32.